By leveraging the specific binding activity of GE11 to EGFR, the engineered exosomes could transfer let-7a miRNA to EGFR-expressing breast cancer xenografts in RAG2 (-/-) mice after intravenous injection, effectively inhibiting tumor development in vivo115. Here, EGFR is linked to breast carcinoma.